CVID in pediatric patients and milder forms Dr. Esther de Vries consultant in pediatric immunology and infectious diseases Jeroen Bosch Hospital, ‘s-Hertogenbosch,

Slides:



Advertisements
Similar presentations
Infections in the Immunocompromised Host
Advertisements

Immunodeficiency K.J. Goodrum Origins of Immunodeficiency Primary or Congenital –Inherited genetic defects in immune cell development or function,
Primary deficiencies of the complement system Radana Zachová Institute of Immunology Faculty hospital Prague, Motol.
X- linked agammaglobulinemia Versailles, France October 22, 2004 INGID.
PRIMARY & SECONDARY ANTIBODY DEFICIENCY.
Immunodeficiency Paula O’Leary CP4004 Lecture Nov 2010.
Alport Syndrome: Dealing with Hearing Loss and Advances in Technology
Asymptomatic hypogammaglobulininemic patients Do we need immunoglobulins? Jiří Litzman, Marcela Vlková, Maria Šárfyová Dept Clin Immunol Allergol, Masaryk.
Immune Deficiency Syndromes in the Appalachia Presented by: Demetrio R. Macariola, M.D. FAAP THINK BEYOND THE BUGS.
Debate re diagnostic criteria Please your comments to:
Clinical and Laboratory Manifestation of Selective IgM Deficiency Jiří Litzman Dept Clin. Immunol. Allergol, St Anne University Hospital Masaryk University,
Case 6 Manzhu Kang, Phil Soto, Ivana Olguin California State University, Los Angeles.
Immunodeficiency K.J. Goodrum Origins of Immunodeficiency Primary or Congenital –Inherited genetic defects in immune cell development or function,
Primary Immunodeficiency Diseases Primary Immunodeficiency Diseases The primary immunodeficiency diseases are a group of disorders in which the primary.
Principles of Immunology Immunodeficiency 4/20/06 ”Wise people talk because they have something to say; fools, because they have to say something” Plato.
Diagnosis and Management of Immunodeficiency in Adulthood Teresa Tarrant, MD Assistant Professor of Medicine Division of Rheumatology, Allergy, and Immunology.
Primary Immunodeficiency Conleth Feighery Dept. of Immunology MSc in Molecular Medicine 2009.
Unit 1 Nature of the Immune System Part 7 Immunodeficiency Diseases
Immunodeficiencies Board Review December 17, 2007.
Impact of HIV on Immunoglobulin Levels in CVID A primary immune deficiency Defined by hypogammaglobulinemia Males and females equally affected Many clinical.
Immunodeficiency: Primary immune deficiency: -Caused by intrinsic or congenital defects. -Over 100 diseases of this type are known in humans, and for many.
leucocytes Benign Disorders
The Wiskott-Aldrich Syndrome: An X-linked Primary Immunodeficiency
Diagnosis of Primary Immunodeficiency
The Immune System – in Health and Diseases
Primary Immunodeficiency Disorders (PID) Soheila Alyasin M.D. AssOCIAT Professor of Pediatrics Division of Immunology and Allergy.
Malignancy  NHL 7.7% - mostly extranodal, all B cell type  Others - –Waldenstrom’s macroglobulinemia –Hodgkin’s disease –Adenocarcinoma - stomach, ovary,
Lecture Immunodeficiencies. Definition Immunodeficiency The inability of the body to produce a sufficient immune response.
Indication for an assessment of immune status. 1. Detailed examination of the human health. 2. Genetic defects of the immune system (primary immunodeficiency).
Quality Assurance for Pneumococcal Assays in Europe Daniel Harrison.
A Patient with Recurring Infections Julia Wright, M.D. Clinical Associate Professor of Medicine Section of General Internal Medicine.
Respiratory presentation of PIDs Dr Somwe Wa Somwe Paediatrician Department of Paediatrics and Child Health UTH.
How much gammaglobulin ? INGID VII th Meeting Budapest, October 7, 2006 Rolf Gustafson.
VILNIUS UNIVERSITY HOSPITAL SANTARISKIU KLINIKOS.
IMMUNODEFICIENCY Lecture Outlines Define immunodeficiency
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
Primary antibody deficiencies in Estonia Sirje Velbri Tallinn Childrens’ Hospital, Estonia.
Iranian Primary Immunodeficiency Registry (IPIDR) The Spectrum of Primary Immunodeficiency Diseases in Iran Iranian Primary Immunodeficiency Registry (IPIDR)
The Pediatric PID Register of Bihor County Ellenes J. Z¹, Ritli L. ¹, Miculschi G. ¹, Mihalceanu R. ¹, Praja M. ¹, Cladovan C. ¹, Spineanu R.
Retrospective case studies of selective IgAD patients Ellenes J. Zoltán MD Childrens’ Hospital Oradea, Romania Prof. Dr. Maródi László Dept. of Infectology.
IMMUNE SYSTEM Dr. Yıldıran different intracellular signaling pathways Dr. Yıldıran2.
The Immune System – in Health and Diseases Dr. Ilan Dalal Pediatric Allergy/Immunology/Infectious Unit Department of Pediatrics E. Wolfson Medical Center,
P-CID patient discussion form. Patient summary y/o boy/girl with: – Infection – Immune dysregulation – T cell deficiency Consanguinity: Family history:
Immunology Chapter 21 Richard L. Myers, Ph.D. Department of Biology Southwest Missouri State Temple Hall 227 Springfield, MO
Chapter 18 AIDS and other Immunodeficiences Dr. Capers
Immunodeficiency diseases. Prof. Mohamed Osman GadElRab. College of Medicine & KKUH.
Immune Deficiency.
Immunology KNH 413. Immunity Body’s ability to recognize material as foreign and to neutralize, eliminate, and/or metabolize it Symptoms from an infectious.
The Study Of Frequency Of Primary ImmunoDeficiency Disorders In Iran And Constructing A Database For Registering The Patients.
Immunology KNH 413. Immunity Body’s ability to recognize material as foreign and to neutralize, eliminate, and/or metabolize it Symptoms from an infectious.
Follow-up of a patient with CERNUNNOS deficiency Edyta Heropolitańska-Pliszka Immunology Department Children’s Memorial Health Institute Warsaw, Poland.
Immune deficiency disorders Dr. Hend Alotaibi Assistant professor & Consultant College of Medicine, King Saud University Dermatology Department /KKUH.
Change in Referral Diagnoses and Diagnostic Delay in Hypogammaglobulinaemic Patients. Jiri Litzman Dept. Clin. Immunol. Allergol Masaryk University, Brno,
PID patients in Motol Radana Zachová Institute of Immunology University hospital Prague Motol, Czech Republic ESID Prague Spring meeting 2005.
Approach to the child with immune based and/or allergic disease.
Hypersensitivity, Autoimmunity and Immunodeficiency Part III Nancy L Jones, MD August 29, 2011.
Immune deficiency disorders
Immune-deficiencies for batch 17-MBBS Yr 1 Dr. P. K. Rajesh. M.D.
IMMUNODEFICIENCY DISORDERS
Immunodeficiency: Antibody
Primary immunodeficiencies in adults (Lithuanian experience)
Immunodeficiency disorders
Primary Immunodeficiency Disorders
Immunology KNH 413.
Common Variable Immunodeficiency
Immunology KNH 413.
Images in immunodeficiency
Stephen Jolles, FRCP, FRCPath, PhD 
CVID- Major features Recurrent pyogenic infections, with onset at any age Increased incidence of autoimmune disease Total immunoglobulin level < 300 mg/dL.
Immunodeficiency disorders
Presentation transcript:

CVID in pediatric patients and milder forms Dr. Esther de Vries consultant in pediatric immunology and infectious diseases Jeroen Bosch Hospital, ‘s-Hertogenbosch, the Netherlands

CVID  What is CVID?  Discussion!  What are ‘milder forms’?  Discussion!

CVID (IUIS)  Common Variable Immunodeficiency Disorders  The International Union of Immunological Societies (IUIS) Primary Immunodeficiency Diseases (PID) Classification Committee: Raif. S. Geha, M.D., Luigi. D. Notarangelo, M.D., Co-chairs, Jean-Laurent Casanova, M.D., Helen Chapel, M.D., Mary Ellen Conley, M.D., Alain Fischer, M.D., Lennart Hammarström, M.D., Shigeaki Nonoyama, M.D., Hans D. Ochs, M.D., Jennifer Puck, M.D., Chaim Roifman, M.D., Reinhard Seger, M.D., and Josiah Wedgwood, M.D  J Allergy Clin Immunol October; 120(4): 776–794.

CVID (IUIS)  Predominantly antibody deficiencies  2. Severe reduction in serum IgG and IgA with normal, low or very low numbers of B cells  CVID: oLow IgG and IgA; variable IgM oAll have recurrent bacterial infections. Clinical phenotypes vary: autoimmune, lymphoproliferative and/or granulomatous disease oApproximately 10% have a positive family history (AR or AD) oAlterations in TACI, BAFFR, Msh5 may act as contributing polymorphisms (A disease-causing effect has been identified for homozygous C140R and A181E TACI mutations)

CVID (ESID/PAGID criteria)  Probable  Male or female patient who has a marked decrease of IgG (at least 2 SD below the mean for age) and a marked decrease in at least one of the isotypes IgM or IgA, and fulfills all of the following criteria:  1) Onset of immunodeficiency at greater than 2 years of age  2) Absent isohemagglutinins and/or poor response to vaccines  3) Defined causes of hypogammaglobulinemia have been excluded (see ' Differential Diagnosis of Hypogammaglobulinemia')

CVID (ESID/PAGID criteria)  Possible  Male or female patient who has a marked decrease (at least 2 SD below the mean for age) in one of the major isotypes (IgM, IgG and IgA) and fulfills all of the following criteria:  1) Onset of immunodeficiency at greater than 2 years of age  2) Absent isohemagglutinins and/or poor response to vaccines  3) Defined causes of hypogammaglobulinemia have been excluded (see ' Differential Diagnosis of Hypogammaglobulinemia')

CVID (ESID/PAGID criteria)  Spectrum of disease  Most patients with CVI are recognized to have immunodeficiency in the second, third or fourth decade of life, after they have had several pneumonias; however children and older adults may be affected. Viral, fungal and parasitic infections as well as bacterial infections may be problematic. The serum concentration of IgM is normal in about half of the patients. Abnormalities in T cell numbers or function are common. The majority of patients have normal numbers of B cells; however, some have low or absent B cells. Approximately 50% of patients have autoimmune manifestations. There is an increased risk of malignancy.

CVID (ESID/PAGID criteria)  Differential diagnosis of hypogammoglobulinemia  Drug Induced –Antimalarial agents –Captopril –Carbamazepine –Glucocorticoids –Fenclofenac –Gold salts –Penicillamine –Phenytoin –Sulfasalazine

CVID (ESID/PAGID criteria)  Genetic Disorders –Ataxia Telangiectasia –Autosomal forms of SCID –Hyper IgM Immunodeficiency –Transcobalamin II deficiency and hypogammaglobulinemia –X-linked agammaglobulinemia –X-linked lymphoproliferative disorder (EBV associated) –X-linked SCID –Some metabolic disorders –Chromosomal Anomalies –Chromosome 18q- Syndrome –Monosomy 22 –Trisomy 8 –Trisomy 21

CVID (ESID/PAGID criteria)  Infectious Diseases –HIV –Congenital Rubella –Congenital infection with CMV –Congenital infection with Toxoplasma gondii –Epstein-Barr Virus  Malignancy –Chronic Lymphocytic Leukemia –Immunodeficiency with Thymoma –Non Hodgkin's lymphoma –B cell malignancy

CVID (ESID/PAGID criteria)  Systemic Disorders –Immunodeficiency caused by hypercatabolism of immunoglobulin –Immunodeficiency caused by excessive loss of immunoglobulins (nephrosis, severe burns, lymphangiectasia, severe diarrhea)  Last updated 2005

CVID  So now we know!  Or not?  How do these patients present themselves?  And when and where?  Discussion!

Clinical presentation of PIDs  Recurrent ENT and airway infections  Failure-to-thrive from early infancy  Recurrent pyogenic infections  Unusual infections or unusually severe course of infections  Recurrent infections with the same type of pathogen  Autoimmune or chronic inflammatory disease; lymphoproliferation  Characteristic combinations of clinical features in eponymous syndromes  Angioedema

Clinical presentation of PIDs  Recurrent ENT and airway infections  Failure-to-thrive from early infancy  Recurrent pyogenic infections  Unusual infections or unusually severe course of infections  Recurrent infections with the same type of pathogen  Autoimmune or chronic inflammatory disease; lymphoproliferation  Characteristic combinations of clinical features in eponymous syndromes  Angioedema

Clinical and Experimental Immunology 2006;145:204–214.  Picking up the signs of PID  Recognizing the different clinical presentations of PID  Following the appropriate diagnostic protocol  Protocol 1: –Rule out severe antibody deficiency and neutropenia –Perform booster responses (specific antibodies), consider IgG-subclasses and M-proteins –Consider lymphocyte subpopulations and further tests –If problems persist, repeat the tests!

Milder forms  IgA deficiency  IgG-subclass deficiency  Specific antibody deficiency –Anti-protein –Anti-polysaccharide

IgA deficiency (ESID/PAGID criteria)  Definitive  Male or female patient greater than 4 years of age who has a serum IgA of less than 7 mg/dl (0.07 g/L) but normal serum IgG and IgM, in whom other causes of hypogammaglobulinemia have been excluded (see 'Differential Diagnosis of Hypogammaglobulinemia'). These patients have a normal IgG antibody response to vaccination.

IgA deficiency (ESID/PAGID criteria)  Probable  Male or female patient greater than 4 years of age who has a serum IgA at least 2 SD below normal for age but normal serum IgG and IgM, in whom other causes of hypogammaglobulinemia have been excluded (see 'Differential Diagnosis of Hypogammaglobulinemia'). These patients have a normal IgG antibody response to vaccination.

IgA deficiency (ESID/PAGID criteria)  Spectrum of disease  Patients with IgA deficiency have an increased incidence of upper respiratory tract infections, allergies and autoimmune disease. Many individuals with IgA deficiency are asymptomatic. Others have persistent or recurrent infections and some develop CVI over time.

IgG-subclass deficiency (ESID/PAGID criteria)  Draft  Male or female patient with recurrent/severe infections and all of the following:  aged 7 years  normal levels of IgM and IgA and at least two of IgG1-3 sublasses less than the 5th centile for age  Poor responses to some vaccines

Specific antibody deficiency  Protein antigen: tetanus, diphtheria  Polysaccharide antigen: pneumococci (Pneumo-23)  Conjugated polysaccharide antigen: Hib  Isohemagglutinins (IgM)

Patient 1  Boy

Patient 1  Boy  2-3 years: atopic eczema, recurrent upper airway infections; adenotonsillectomy; Henoch Schönlein purpura  PID? Discussion!

Patient 1  Boy  2-3 years: atopic eczema, recurrent upper airway infections; adenotonsillectomy; Henoch Schönlein purpura  5 years: bronchial hyperreactivity (cough), glue ears; inhalers; no specific IgE’s; IgG 6.6 IgA 0.56 IgM 0.88 IgG IgG IgG IgG g/l  PID? Discussion!

Patient 1  Boy  2-3 years: atopic eczema, recurrent upper airway infections; adenotonsillectomy; Henoch Schönlein purpura  5 years: bronchial hyperreactivity (cough), glue ears; inhalers; no specific IgE’s; IgG 6.6 IgA 0.56 IgM 0.88 G IgG IgG IgG g/l  7 years: IgG 6.7 IgA 0.40 IgM 0.32 IgG IgG IgG IgG g/l  Started in trial cotrim vs IVIG prophylaxis

Patient 2  Girl

Patient 2  Girl  2 years: recurrent upper airway infections, bronchial hyperreactivity, adenoidectomy, tympanostomy tubes  PID? Discussion!

Patient 2  Girl  2 years: recurrent upper airway infections, bronchial hyperreactivity, adenoidectomy, tympanostomy tubes  3 years: no improvement IgG 5.0 IgA 0.47 IgM 0.6 IgG IgG IgG IgG g/l Diphtheria > 2.24, Tetanus > 3.06 IU/ml Pneumococci serotype 3: 7 -> 52, 4: 3 -> 22, 9: 1 -> 16 U/ml PID? Discussion!

Patient 2  4 years: recurrent otitis, very tired and listless, cotrim prophylaxis little effect IgG 3.0 IgA 0.27 IgM 0.5 IgG IgG IgG IgG 4 <0.04 g/l Pneumococci serotype 3: 7, 4: 5, 9: 3 U/ml B-lymphocytes 0.6 x 10 9 /l  PID? Discussion!  Therapy? Discussion!

Patient 2  4 years: recurrent otitis, very tired and listless, cotrim prophylaxis little effect IgG 3.0 IgA 0.27 IgM 0.5 IgG IgG IgG IgG 4 <0.04 g/l Pneumococci serotype 3: 7, 4: 5, 9: 3 U/ml B-lymphocytes 0.6 x 10 9 /l  Started on IVIG and is doing very well now (after ENT-surgery of the middle ear)

Patient 3  Boy

Patient 3  Boy  2 years: very tired, upper respiratory infections; mother very tired too, lots of infections as a child, and still recurrent sinusitis  PID? Discussion!  Therapy? Discussion!

Patient 3  Boy  2 years: very tired, upper respiratory infections; mother very tired too, lots of infections as a child, and still recurrent sinusitis IgG 2.5 IgA <0.25 IgM 0.24 IgG IgG IgG IgG 4 <0.01 g/l Diphtheria >0.55, Tetanus > 3.60 IU/ml Pneumococci serotype 3: 1, 4: <1, <1 U/ml  PID? Discussion!  Therapy? Discussion!

Patient 3  Boy  2 years: very tired, upper respiratory infections; mother very tired too, lots of infections as a child, and still recurrent sinusitis IgG 2.5 IgA <0.25 IgM 0.24 IgG IgG IgG IgG 4 <0.01 g/l Diphtheria >0.55, Tetanus > 3.60 IU/ml Pneumococci serotype 3: 1, 4: <1, <1 U/ml  Started on IVIG, is doing very well

Patient 4  Girl

Patient 4  Girl  5 years: recurrent airway infections, bronchial hyperreactivity Diphtheria 0.74 Tetanus 2.05 IU/ml Pneumococci serotype 3: 75 -> 107, 4: 3 -> 62, 9: 7 -> 27 U/ml  PID? Discussion!

Patient 4  Girl  5 years: recurrent airway infections, bronchial hyperreactivity Diphtheria 0.74 Tetanus 2.05 IU/ml Pneumococci serotype 3: 75 -> 107, 4: 3 -> 62, 9: 7 -> 27 U/ml  8 years: bronchial hyperactivity, chronic cough with sputum, cotrim prophylaxis some effect IgG 8.0 IgA 1.52 IgM 0.8 IgG IgG IgG IgG g/l Pneumococci serotype 3: 16, 4: 13, 9: 6 U/ml Diphtheria after booster 6.32, Tetanus>16 IU/ml PID? Discussion!

Patient 4  12 years: start IVIG, much better IgG 8.0 IgA 1.52 IgM 0.8 IgG IgG IgG IgG g/l Pneumococci serotype 3: 14 -> 50, 4: 11 -> 44, 9: 6 -> 26 U/ml  15 years: switched to scIG

CVID and milder forms  Quite a challenge for the pediatric immunologist!  Thank you for your attention!